Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05160987 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effect of Remimazolam With Protocolized Sedation on Critical Ill, Mechanical Ventilated Patients Compared With Midazolam

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Dec 31, 2024 to Nov 30, 2027 Completion date: Dec 31, 2024 to Dec 31, 2027v5 Show 1 more changeShow less
    • Completion date: Dec 31, 2024 to Dec 31, 2027
  2. Secondary endpoints: 8 to 6 Collaborators: 9 to 7 · Eligibility criteria shortened, about 5 wordsv4 Show 2 more changesShow less
    • Collaborators: 9 to 7
    • Eligibility criteria shortened, about 5 words

    See this version in full on ClinicalTrials.gov ↗

  3. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Feb 2022 to Mar 29, 2022 · Site details revisedv3 Show 2 more changesShow less
    • Start date changed from estimate of Feb 2022 to Mar 29, 2022
    • Site details revised
  4. Start date: Jan 1, 2022 to Feb 2022 Collaborators: 14 to 9v2 Show 1 more changeShow less
    • Collaborators: 14 to 9

    See this version in full on ClinicalTrials.gov ↗

  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
In this parallel, multicenter, single-blind randomized controlled trial, mechanical ventilated patients will be randomly assigned to two groups. One receives remimazolam to achieve sedation goals, while the other receives Midazolam. The primary outcome is the effect of remimazolam on duration of mechanical ventilated of critical patients compared to midazolam.
Trial Details
NCT Number NCT05160987
Lead Sponsor Zhujiang Hospital
Collaborators: Integrated traditional Chinese and Western Medicine Hospital of Southern Medical University, First Affiliated Hospital of Shantou University Medical College, Affiliated Hospital of Guangdong Medical University, Yunfu People's Hospital, Zhongshan Hospital Of Traditional Chinese Medicine, Guangdong Province Traditional Medical hospital, The Third Affiliated Hospital of Guangzhou Medical University
Conditions Sedation and Analgesia
Enrollment 440 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov